Project Grant HT94252410791

The Cooperative Agreement award of $336,748.00 from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121) aims to develop and test a caregiver-implemented early speech and language intervention model for toddlers with non-syndromic cleft lip and/or palate (NSCL/P). The project will evaluate the effectiveness of the Caregiver-Implemented Enhanced Milieu Teaching with Phonological Emphasis (EMT+PE)...

This Project Grant award of $435,875.00, provided by the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), supports research to determine what information and resources parents and professionals in Pennsylvania need to support language acquisition in deaf and hard-of-hearing (DHH) children. The research team at Temple University will first gather input from inexperienced parents and professionals currently...

This $847,242 federal Project Grant award from the Department of Education's Institute of Education Sciences (CFDA 84.324 - Research in Special Education) supports a research project titled "Partnership to Build Teacher Capacity to Promote Early Language Learning in Infants and Toddlers with and at Risk for Disabilities". The primary awardee, the University of Kansas Center for Research Inc., will collaborate with the University of North Carolina at Chapel Hill to document the efficacy...

This Project Grant award of $461,995.00 from the National Institutes of Health's (NIH) Trans-NIH Research Support program (CFDA 93.310) supports a qualitative investigation into the factors that influence families of late-talking children to pursue early communication evaluations before age three. The study, titled "Learning from Success Stories: A Qualitative Investigation of Factors Influencing Families of Late Talkers to Pursue Communication Evaluations Before Age Three", aims to...

This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $441,250 to the University of California, Davis (UC Davis) to develop and validate a telehealth-delivered expressive language assessment tool for individuals with Down syndrome. The project aims to expand the accessibility and language capabilities of the Expressive Language Sampling-Narrative (ELS-N) procedure, which has shown promise as a psychometrically...

The federal Project Grant award of $439,916 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders (CFDA 93.173) program, is focused on "Breaking Barriers: Harnessing Implementation Mapping to Promote Caregiver Coaching in Early Intervention." The project aims to develop and test implementation strategies that address barriers to the widespread use of caregiver coaching in early...

This Project Grant award of $435,875 from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) will be used by Vanderbilt University to address issues with the reliability and generalizability of research on late-language emergence, or "late-talking," in children. The project aims to: 1) Increase the availability of data on late-talkers by curating and ingesting existing datasets into a data repository, 2) Integrate the datasets using...

The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $743,412 Project Grant (CFDA 93.173 - Research Related to Deafness and Communication Disorders) to the University of Oregon. The goal of this 5-year project is to evaluate the comparative effectiveness and implementation outcomes of different parent-implemented naturalistic communication intervention (PI-NCI) modalities for improving parent responsivity and child communication/language outcomes among...

This $411,925 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program will support research to delineate the molecular mechanisms underlying the developmental defects caused by TAR syndrome. The primary objectives are to examine the role of the RBM8A gene in forelimb development and evaluate the effects of RBM8A reinstatement therapy in a TAR mouse model. The anticipated outcomes include...

This $2,308,368 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) supports research to investigate the relationship between visual attention, multimodal communication cues, and expressive language development in typically developing children and those with autism spectrum disorder (ASD). The research, led by Vanderbilt University Medical Center, will leverage existing datasets and conduct new...